Clinical Trial Update: Adipose Derived Stem Cell Therapy for Autism [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating adipose-derived stem cell therapy for autism was withdrawn from Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Adipose-derived stem cell therapy

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Autism | Phase 1, Phase 2 | Status: WITHDRAWN